(Q41240640)

28 September 2017

1 reference

title

The role of the old and the new antiepileptic drugs in special populations: mental and multiple handicaps (English)

1 reference

28 September 2017

0 references

R H Mattson

1

1 reference

28 September 2017

publication date

1 January 1996

1 reference

28 September 2017

1 reference

28 September 2017

volume

37 Suppl 6

1 reference

28 September 2017

page(s)

S45-53

1 reference

The diversity of epilepsy in adults with severe developmental disabilities: age at seizure onset and other prognostic factors.

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1996.TB06039.X

Some issues in the assessment of epilepsy occurring in the context of learning disability in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1996.TB06039.X

Unprovoked seizures and developmental disabilities: clinical characteristics of children referred to a child development center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1996.TB06039.X

Epilepsy in children: prevalence, disability, and handicap

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1996.TB06039.X

Comparative cognitive effects of anticonvulsants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1996.TB06039.X

A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1996.TB06039.X

Carbamazepine--A double-blind comparison with phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1996.TB06039.X

Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1996.TB06039.X

Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1996.TB06039.X

Lamotrigine for the treatment of epilepsy in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1996.TB06039.X

Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Sabril IS Investigator and Peer Review Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1996.TB06039.X

Effect of vigabatrin on epilepsy in mentally retarded patients: a 7-month follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1996.TB06039.X

Long-term antiepileptic efficacy of vigabatrin in drug-refractory epilepsy in mentally retarded patients. A 5-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1996.TB06039.X

Gabapentin toxicity in children manifesting as behavioral changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1996.TB06039.X

Parenteral antiepileptic/anticonvulsant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1996.TB06039.X

A controlled trial of diazepam administered during febrile illnesses to prevent recurrence of febrile seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1996.TB06039.X

Reduced bioavailability of moisture-exposed carbamazepine resulting in status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1996.TB06039.X

Generic substitutions for antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1996.TB06039.X

10.1111/J.1528-1157.1996.TB06039.X

21 January 2018

Identifiers

DOI

1 reference

28 September 2017

1 reference